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Introduction
The use of blood transfusion dates back to the mid-17th
century. By the early 1900s blood transfusion emerged as a
standard of clinical practice that was perceived as relatively
free of risk. The value of blood transfusion was largely
unchallenged until the early 1980s, when transfusion-related
disease transmission, particularly HIV transmission, became a
huge public health concern. Intense scrutiny and evaluation of
transfusion practice and its risk/benefit balance followed.
Adverse effects of allogeneic blood transfusion
Clearly, the view of blood transfusion as risk free is no longer
valid. Adverse consequences of red blood cell (RBC) trans-
fusion include the following: hemolytic and non-hemolytic
transfusion reactions, transmission of infectious agents, trans-
fusion of contaminated RBCs, and transfusion-mediated
immunomodulation.
The first indication that immune modulation secondary to allo-
geneic blood transfusion existed in humans was reported
more than 25 years ago, when Opelz and colleagues [1]
observed improved renal allograft survival with pretransplant
allogeneic RBC transfusions. More recently, Opelz and
coworkers [2] reported a clear improvement in renal allograft
survival with allogeneic blood transfusion in addition to
modern immunosuppressive therapy. Moreover, allogeneic
blood transfusion-associated immunosuppression has been
associated with a decreased recurrence rate of spontaneous
abortion in affected women [3] and a reduced clinical relapse
rate in patients with chronic inflammatory bowel disease [4].
It has also been argued that immunosuppressive effects of
allogeneic blood transfusion might adversely affect the
outcome of patients undergoing curative operation for malig-
nancy [5]. In addition, several clinical studies demonstrated
that allogeneic transfusion is an independent risk factor for
postoperative bacterial infections [6,7].
Although most emphasis has been placed on immune suppres-
sion following transfusion, it has become evident that proinflam-
matory effects may be important as well. Cytokines and other
inflammatory mediators have been shown to accumulate during
storage of blood products [8,9]. Plasma from stored RBCs has
been demonstrated to prime the oxidase system in neutrophils
(even if leukoreduced), delay apoptosis, and activate endothe-
lial cells [10,11], setting the stage for neutrophil-mediated
tissue destruction and organ failure. Indeed, several investiga-
tors have identified blood transfusion as an independent risk
factor for postinjury multiple organ failure (MOF) [12,13].
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Abstract
During the past 20 years, the perceived value of blood transfusions has changed as it has become
appreciated that transfusions are not without risk. Red blood cell transfusion has been associated with
disease transmission and immunosuppression for some time. More recently, proinflammatory
consequences of red blood cell transfusion have also been documented. Moreover, it has become
increasingly evident that stored red blood cells undergo time-dependent metabolic, biochemical, and
molecular changes. This ‘storage lesion’ may be responsible for many of the adverse effects of red
blood cell transfusion. Clinically, the age of blood has been associated with multiple organ failure,
postoperative pneumonia, and wound infection. The relationship between age of blood and clinical
adverse effects needs further study.
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Red blood cell storage lesion
The advancement of transfusion medicine as a specialty has
paralleled our ability to store blood ex vivo in its liquid state.
As storage techniques have improved and extended the
storage period up to 42 days, there has been a shift from
focusing on maintaining RBC viability to including the quality
of transfused RBCs as well.
The ‘storage lesion’ has been defined as the constellation of
changes to the RBC that occur during storage, including
metabolic, biochemical, and molecular changes, which even-
tually result in irreversible damage and ultimately limit the
storage period [14]. Although the term traditionally has been
restricted to corpuscular damage, recent evidence shows
that a number of bioreactive substances accumulate in the
medium during storage [8,9,11]. Selected changes charac-
teristic of the storage lesion and their potential consequences
are listed in Table 1.
We have been particularly interested in the relationship
between blood transfusion and neutrophil priming. Silliman
and coworkers [10] demonstrated that, during routine
storage of whole blood and packed RBCs, agents were gen-
erated that significantly primed the NADPH (nicotinamide
adenine dinucleotide phosphate, reduced form) oxidase
system. This effect was not significant until after 2 weeks of
storage and was maximal by by the time all of the compo-
nents were out of date. Those authors subsequently showed
that this effect was largely due to accumulation of proinflam-
matory lipids, in particular lysophosphatidylcholines [15].
Evidence of clinical relevance
Despite the relative wealth of data regarding the changes
related to storage of blood products, evidence of clinical
significance has been sparse. As noted earlier, multiple
studies now document adverse effects of allogeneic blood
transfusion. The relationship between these adverse effects
and the age of transfused blood, however, has not been
adequately studied.
RBC transfusions are frequently advocated to increase
oxygen delivery in critically ill patients. The immediate effec-
tiveness of this therapy in increasing systemic oxygen uptake
is questionable because storage depresses the ability of
RBCs to deform as well as unload oxygen peripherally.
Because 2,3-diphosphoglycerate and deformability recover in
vivo following transfusion, one would expect to see a delayed
increase in systemic oxygen consumption after RBC transfu-
sion. Marik and Sibbald [16], however, noted no improvement
in systemic oxygen consumption for up to 6 hours after trans-
fusion. Moreover, those authors noted an unexpected
decrease in gastric intramucosal pH (measured by gastric
tonometry) following transfusion with blood stored for longer
than 15 days. They suggested that transfusion of old, poorly
deformable RBCs leads to microcapillary sludging and
obstruction, resulting in gut ischemia.
In light of the potential for stored RBC transfusion to adversely
affect oxygen delivery and uptake, Purdy and colleagues [17]
studied the relationship between the age of transfused blood
and survival in critically ill septic patients. The authors retro-
spectively studied 31 patients admitted to their intensive care
unit with severe sepsis. The number of units of packed RBCs
transfused and the age of each unit was determined using
blood bank records. There was no difference between
survivors (n = 12) and nonsurvivors (n = 19) in age, sex, inten-
sive care unit length of stay, incidence of septic shock, Acute
Physiology and Chronic Health Evaluation II score, or total
number of packed RBCs transfused. Nonsurvivors, however,
were transfused with significantly older RBCs (median 24 days
versus 21 days in survivors; P < 0.0001). Survivors were trans-
fused with a greater proportion of RBCs that were less than
10 days old (85%), whereas nonsurvivors received a greater
proportion of RBCs that were greater than 20 days old (76%).
Table 1
Red blood cell storage lesion
Storage effects Consequences
Decreased 2,3-diphosphoglycerate Increased oxygen affinity and decreased oxygen unloading by hemoglobin
ATP depletion Erythrocyte shape changes
Increased osmotic fragility
Decreased deformability
Microvesiculation and loss of lipid membrane Decreased erythrocyte viability
Lipid peroxidation Cellular injury and death
Bioactive substance generation: histamine, cytokines, lipids Febrile transfusion reactions
Neutrophil priming/endothelial activation
Cellular injury
Transfusion-related acute lung injury
Multiple organ failure (?)S26
Vamvakas and Carven [18] investigated the association
between the duration of storage of transfused RBCs and
postoperative infection following coronary artery bypass graft
surgery. They observed that the mean duration of storage of
all transfused RBCs was a significant predictor of postopera-
tive pneumonia and wound infection. The risk for pneumonia
increased by 1% per day of mean RBC storage time. Age of
transfused RBCs remained a significant predictor of post-
operative infection after controlling for other known risk factors.
Blood transfusion has consistently been shown to be a major
risk factor for postinjury MOF. Initially, transfusion require-
ment was thought to be a surrogate for injury severity, but
multiple studies have demonstrated it to be a robust and
independent predictor of postinjury MOF [12,13].
We previously demonstrated that old, but not outdated,
packed RBC plasma primes neutrophils for superoxide
production [15]. Furthermore, old blood plasma activates
endothelial cells in a dose- and age-dependent fashion [11].
The concordant activation of endothelial cells and priming
followed by activation of neutrophils is crucial to the develop-
ment of postinjury MOF.
To investigate the clinical relevance of these laboratory data,
we performed a multivariate analysis of trauma patients who
received transfusions to examine the effects of the age of
stored blood on the development of postinjury MOF [19]. We
observed that patients who developed MOF received signifi-
cantly older packed RBC units and, furthermore, that the age
of the units was an independent predictor of MOF.
Conclusion
Current evidence shows that metabolic, biomechanical, and
molecular changes occur during the storage of blood products.
Data are accumulating that these changes may lead to harmful
consequences in the recipient. Further studies are necessary
to clarify this relationship. Changes in blood banking practice
(i.e. leukocyte reduction), clinical practice (i.e. lower transfusion
‘trigger’, recombinant erythropoietin), and continued develop-
ment of blood substitutes may facilitate avoidance of the
adverse effects of allogeneic blood transfusion.
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